Kamala Harris May Offer a 'Different Face' for American Voters
*By Brian Henry*
Now that Kamala Harris, a freshman senator and recent entrant to national politics, has joined the already-crowded 2020 race for president, political watchers are eager for clues about her ability to maneuver a high-stakes election. But Senator Harris has minimal experience on the national stage ー so her track record in California as an Attorney General will be essential evidence to Democratic voters.
"Her list of legislative accomplishments is rather thin," said Joe Garofoli, senior political writer at the San Francisco Chronicle.
"When you look at her AG career, she was sort of a mix of being bold and yet cautious and innovative," Garofoli told Cheddar.
One of her biggest victories came during the mortgage crisis. Harris pulled California out of the nationwide mortgage settlement talks.
"That was a gutsy move for a first term attorney general, California ended up with $20 billion dollars," Garofoli said.
As Attorney General, Garofoli said Harris also took a unique approach to criminal justice reform.
"She's offered implicit bias training at the Department of Justice and she focused on things like truancy issues. Most criminals are dropouts and she said, 'let's examine the root cause of this.'"
That victory aside, Harris has been criticized for neglecting to use the power of her office to investigate police shootings in California, and leaving it up to the locals instead.
Should she clinch the nomination, Harris will likely face questions over her record as San Francisco's District Attorney.
Harris, who opposed capitol punishment, chose not to pursue the death penalty after a police officer was shot in the line of duty by a gang member.
"There was a lot of blow back from law enforcement," Garfoli said. "You know President Trump is going to go after this one day one."
Even still, Harris' background gives her a distinct advantage over her progressive opponents.
"She's half-Indian American and her father was born and raised in Jamaica. She's the child of immigrants. She's a different face for voters, not just for Democratic voters but for all American voters."
Jill and Carlo cover the latest on Omicron, another school shooting in America and more. Plus, bidding farewell to 'transitory' inflation, and the controversy surrounding 'Lovely Bones' author Alice Sebold.
Disparities in tree coverage across America is a huge issue that affects air quality, heat exposure, and ultimately determines how resilient communities are against climate change. The Build Back Better Act is allocating $2.5 billion to boost 'tree equity.' Lemir Teron, assistant professor at SUNY College of Environmental Science and Forestry, joins Cheddar News to explain why this is a priority for Democrats today.
The Supreme Court will be hearing arguments in Dobbs v. Jackson Women's Health on Wednesday over a Mississippi law banning abortions after 15 weeks. Jimmy Hoover, the Supreme Court editor-at-large for Law360, joined Cheddar to break down the momentous legal fight. "This is the biggest abortion case at the Supreme Court in 30 years," he said. "It is a … a direct challenge to Roe v. Wade."
Matt Peron, Director of Research at Janus Henderson Investors, joins Cheddar News' Closing Bell, where he breaks down the factors leading to today's market slide and says there's more to it than Fed Chair Jerome Powell's comments about speeding up tapering efforts.
Walmart CEO Dough McMillon praised the Biden administration's efforts to ease supply chain constraints after the company saw a 26 percent jump in shipments over the last month. President Joe Biden had announced back in October that California ports would operate on a 24/7 basis.
Jill and Carlo cover the latest developments with the Omicron variant that are spooking markets once again. Twitter's @Jack is leaving, SCOTUS takes up abortion rights and the world has a brand new republic.
The Biden Administration is set to buy 10 million courses of Pfizer's Covid pill if it gains emergency use authorization from the FDA. With this purchase, the U.S. will receive more than 13 million courses of antiviral pills aimed at treating Covid and reducing severe illness and death. Pfizer's pill has been shown to reduce risk of hospitalization and death by 89 percent, proving it could be a key tool in the fight against the pandemic. Dr. Soumi Eachempati, Co-Founder, CEO & CMO of Cleared4, joined Cheddar News to discuss.
